dr. daud on the challenges of treating metastatic melanoma with braf inhibitor monotherapy
Published 10 years ago • 332 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:14
dr. daud on the combinations of immunotherapy for melanoma
-
1:53
dr. daud on challenges facing the treatment landscape for melanoma
-
1:32
adil daud, md: optimal sequencing for braf-mutant melanoma patients
-
1:38
adil daud, md: sequencing challenges
-
3:09
challenges facing the field of melanoma
-
2:15
dr. daud discusses the immunogenicity of melanoma
-
2:10
adil daud, md: frequency of missed braf alterations
-
0:42
how to treat braf positive patients with metastatic melanoma? | onc brothers #2023 #oncology #cancer
-
6:33
treatment of braf-mutant metastatic melanoma
-
5:31
treating braf-mutated metastatic melanoma
-
2:58
role of braf mutation in the treatment for melanoma
-
1:25
dr. ribas on the outlook for braf inhibitors in melanoma
-
6:12
braf as a driver in melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
1:06
dr. infante on the future of braf inhibitors in melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
1:09
dr. atkinson discusses braf-mutant metastatic melanoma
-
0:52
adil daud, md: ordering braf reflexively upon diagnosis